查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532649

辣根過氧化物酶市場- 底物（顯色[TMB、ABTS、OPD]、化學發光、螢光、發光、電化學）、等級（I、II、III）、應用（免疫測定[ELISA、BLOT] 、生物感測器）、最終用戶-全球預測（2024 - 2032）

Horseradish Peroxidase Market - Substrate (Chromogenic [TMB, ABTS, OPD], Chemiluminescent, Fluorogenic, Luminescent, Electrochemical), Grade (I, II, III), Application (Immunoassays [ELISA, BLOT], Biosensors), End-user- Global Forecast (2024 - 2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在各個科學和醫學領域的研發活動激增的推動下，2024 年至 2032 年間，全球辣根過氧化物酶市場的複合年成長率將達到 7.5%。 HRP 是一種多功能酶，因其高催化活性和穩定性而廣泛用於診斷測定，特別是酶聯免疫吸附測定 (ELISA) 和免疫組織化學。生物技術和分子生物學的最新進展擴大了 HRP 的應用，推動了對該酶的需求增加。

診斷技術的創新，例如更靈敏、更準確的檢測，是推動市場需求的關鍵因素。研究人員和醫療專業人員正在不斷探索 HRP 的新應用，包括個人化醫療、環境監測和生物標記發現等新興領域。先進的基於 HRP 的系統和設備的開發提高了診斷程序的準確性和效率，有助於該酶的日益普及。

此外，對早期疾病檢測和診斷能力提高的日益關注正在加速對 HRP 等高性能酶的需求。隨著研究的進展和新技術的開發，辣根過氧化物酶市場預計將持續成長，該酶在推進科學研究和醫學診斷方面發揮關鍵作用。

辣根過氧化物酶產業的整體價值根據底物、等級、應用、最終用戶和地區進行分類。

根據底物，來自螢光部分的辣根過氧化物酶市場收入將在2024 年至2032 年實現值得稱讚的複合年成長率。提高診斷測試的敏感度和特異性。這些螢光檢測廣泛應用於研究和臨床診斷，提供精確、即時的結果。 HRP 在各種螢光應用（例如 ELISA 和分子成像）中的多功能性推動了其日益普及。隨著對更準確、更有效率的診斷工具的需求不斷成長，螢光檢測中對 HRP 的需求預計將顯著增加。

就等級而言，從2024 年到2032 年，II 級細分市場將出現顯著成長。測定和診斷測試。其在酵素連結免疫吸附測定 (ELISA) 和其他免疫測定中的使用受益於 II 級 HRP 的可靠性和低背景干擾。隨著研究和診斷技術的進步，對 II 級 HRP 等高品質試劑的需求正在擴大。這一趨勢推動了市場的成長，反映了酵素在獲得準確和可重複結果方面的重要作用。

歐洲辣根過氧化物酶市場從2024 年到2032 年將呈現顯著的複合年成長率。診斷應用中的高效率。歐洲嚴格的監管標準確保了對 HRP 等高品質、可靠試劑的需求。此外，對醫療保健和生物技術研究的投資不斷增加，也推動了對基於 HRP 的解決方案的需求。隨著歐洲研究人員和醫療保健提供者尋求創新和精確的診斷工具，HRP 市場不斷擴大，反映了其在推動醫學科學方面的關鍵作用。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 疾病診斷中免疫分析的需求不斷增加
      • 生物醫學研究投資不斷增加
      • 對藥物開發和藥物品質控制的需求不斷成長
      • 酶工程和生產的進展
    • 產業陷阱與挑戰
      • 與原料持續供應相關的風險
      • 與儲存和保存期限短有關的問題
  • 成長潛力分析
  • 未來市場趨勢
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按基材分類，2021 - 2032 年

  • 主要趨勢
  • 顯色
    • TMB（3,3',5,5'-四甲基聯苯胺）
    • ABTS（2,2'-偶氮雙[3-乙基苯並噻唑啉-6-磺酸]-二銨鹽）
    • OPD（鄰苯二胺二鹽酸鹽）
  • 化學發光
  • 螢光
  • 發光
  • 電化學

第 6 章：市場估計與預測：依等級，2021 - 2032

  • 主要趨勢
  • 一級
  • 二級
  • 三級

第 7 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 免疫測定
    • 酵素連結免疫吸附試驗
    • 印跡測試
    • 其他免疫測定
  • 生物感測器

第 8 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

  • 主要趨勢
  • 診斷中心
  • 生物製藥公司
  • 學術和研究中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Abcam Limited
  • Abnova Corporation
  • BBI Solutions
  • Bio-rad Laboratories, Inc.
  • Creative Enzymes
  • Enzo Life Sciences, Inc.
  • F. Hoffman-La Roche Ltd.
  • Faizyme Laboratories (Pty) Ltd
  • GenScript
  • Merck KGaA
  • Oriental Yeast Co., Ltd.
  • Promega Corporation
  • Santa Cruz Biotechnology, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
簡介目錄
Product Code: 9712

Global Horseradish Peroxidase Market will witness 7.5% CAGR between 2024 and 2032, driven by the surge in research and development activities across various scientific and medical fields. HRP is a versatile enzyme widely used in diagnostic assays, particularly in enzyme-linked immunosorbent assays (ELISAs) and immunohistochemistry due to its high catalytic activity and stability. Recent advancements in biotechnology and molecular biology have expanded the applications of HRP, fueling increased demand for this enzyme.

Innovations in diagnostic technologies, such as more sensitive and accurate assays, are a key factor driving market demand. Researchers and medical professionals are continuously exploring new applications for HRP, including in emerging fields like personalized medicine, environmental monitoring, and biomarker discovery. The development of advanced HRP-based systems and devices enhances the accuracy and efficiency of diagnostic procedures, contributing to the enzyme's growing popularity.

Furthermore, the expanding focus on early disease detection and improved diagnostic capabilities is accelerating the need for high-performance enzymes like HRP. As research progresses and new technologies are developed, the horseradish peroxidase market is expected to see continued growth, driven by the enzyme's pivotal role in advancing scientific research and medical diagnostics.

The overall Horseradish Peroxidase Industry value is classified based on the substrate, grade, application, end-user, and region.

Based on substrate, the horseradish peroxidase market revenue from the fluorogenic segment will register a commendable CAGR from 2024 to 2032. HRP's enzymatic activity is harnessed in fluorogenic detection methods, where it catalyzes reactions that produce fluorescent signals, enhancing the sensitivity and specificity of diagnostic tests. These fluorogenic assays are widely employed in research and clinical diagnostics, offering precise and real-time results. The versatility of HRP in various fluorogenic applications, such as in ELISAs and molecular imaging, drives its rising popularity. As the need for more accurate and efficient diagnostic tools grows, the demand for HRP in fluorogenic assays is expected to expand significantly.

In terms of grade, the grade II segment will witness an appreciable growth from 2024 to 2032. Grade II HRP, known for its high purity and consistent performance, is increasingly utilized in sensitive assays and diagnostic tests where precision is crucial. Its use in enzyme-linked immunosorbent assays (ELISAs) and other immunoassays benefits from Grade II HRP's reliability and low background interference. As research and diagnostic technologies advance, the need for high-quality reagents like Grade II HRP is expanding. This trend drives market growth, reflecting the enzyme's essential role in achieving accurate and reproducible results.

Europe horseradish peroxidase market will exhibit a notable CAGR from 2024 to 2032. European laboratories and medical facilities increasingly rely on HRP for its high efficiency in enzyme-linked immunosorbent assays (ELISAs), immunohistochemistry, and other diagnostic applications. The stringent regulatory standards in Europe ensure the need for high-quality, reliable reagents like HRP. Additionally, growing investments in healthcare and biotechnology research are fueling the demand for HRP-based solutions. As European researchers and healthcare providers seek innovative and precise diagnostic tools, the market for HRP continues to expand, reflecting its critical role in advancing medical science.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for immunoassays in disease diagnosis
      • 3.2.1.2 Growing investments in biomedical research
      • 3.2.1.3 Growing demand for drug development and drug quality control
      • 3.2.1.4 Advances in enzyme engineering and production
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk related to consistent availability of raw materials
      • 3.2.2.2 Concerns related to storage and low shelf life
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Substrate, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Chromogenic
    • 5.2.1 TMB (3,3',5,5'-tetramethylbenzidine)
    • 5.2.2 ABTS (2,2'-azinobis [3- ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
    • 5.2.3 OPD (ophenylenediamine dihydrochloride)
  • 5.3 Chemiluminescent
  • 5.4 Fluorogenic
  • 5.5 Luminescent
  • 5.6 Electrochemical

Chapter 6 Market Estimates and Forecast, By Grade, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Grade I
  • 6.3 Grade II
  • 6.4 Grade III

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Immunoassays
    • 7.2.1 ELISA
    • 7.2.2 BLOT test
    • 7.2.3 Other immunoassays
  • 7.3 Biosensors

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Diagnostic centers
  • 8.3 Biopharmaceutical companies
  • 8.4 Academic and research centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abcam Limited
  • 10.2 Abnova Corporation
  • 10.3 BBI Solutions
  • 10.4 Bio-rad Laboratories, Inc.
  • 10.5 Creative Enzymes
  • 10.6 Enzo Life Sciences, Inc.
  • 10.7 F. Hoffman-La Roche Ltd.
  • 10.8 Faizyme Laboratories (Pty) Ltd
  • 10.9 GenScript
  • 10.10 Merck KGaA
  • 10.11 Oriental Yeast Co., Ltd.
  • 10.12 Promega Corporation
  • 10.13 Santa Cruz Biotechnology, Inc.
  • 10.14 Takara Bio Inc.
  • 10.15 Thermo Fisher Scientific Inc.